2024澳科资料1688-资料免费精选
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.04.24
2024澳科资料1688：监事会决议公告
2025.04.24
2024澳科资料1688：关于依诺肝素钠注射液获得南非药品注册批件的公告
2025.04.24
2024澳科资料1688：关于向全资子公司天道医药（香港）有限公司增资的进展公告
2025.04.24
2024澳科资料1688：董事会决议公告
2025.04.02
2024澳科资料1688：关于举行2024年度业绩说明会的公告
2025.03.28
2024澳科资料1688：年度关联方资金占用专项审计报告
2025.03.28
2024澳科资料1688：年度股东大会通知
2025.03.28
2024澳科资料1688：内部控制自我评价报告
2025.03.28
2024澳科资料1688：内部控制审计报告
2025.03.28
2024澳科资料1688：关于修订第二期员工持股计划和第三期员工持股计划的公告
第一页
上一页
1
2
3
4
5
下一页
最后一页
